Ohio Public Employees Retirement System (OPERS)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-48,424
Closed -$41.6K 2036
2023
Q4
$41.6K Hold
48,424
﹤0.01% 1602
2023
Q3
$52K Hold
48,424
﹤0.01% 1538
2023
Q2
$125K Sell
48,424
-1,000
-2% -$3.57K ﹤0.01% 1425
2023
Q1
$202K Hold
49,424
﹤0.01% 1392
2022
Q4
$248K Buy
+49,424
New +$310K ﹤0.01% 1376
2022
Q2
Sell
-18,277
Closed -$279K 2050
2022
Q1
$279K Sell
18,277
-12,755
-41% -$199K ﹤0.01% 1445
2021
Q4
$550K Hold
31,032
﹤0.01% 1329
2021
Q3
$652K Buy
+31,032
New +$683K ﹤0.01% 1312

Other funds holding NGM

Ohio Public Employees Retirement System (OPERS)'s NGM Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2024, closing a stake of 48,424 shares — an estimated $41.6K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in NGM in Q3 2021 and held it in 8 quarters. The position peaked at $652K in Q3 2021. 75 funds tracked by Wall St. Rank hold NGM as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 48,424 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $41.6K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s NGM Biopharmaceuticals, Inc. Common Stock position peaked at $652K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.